(19)
(11) EP 1 424 930 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.06.2011 Bulletin 2011/24

(45) Mention of the grant of the patent:
06.04.2011 Bulletin 2011/14

(21) Application number: 02757661.0

(22) Date of filing: 09.09.2002
(51) International Patent Classification (IPC): 
A61B 10/00(2006.01)
A61B 19/00(2006.01)
 A61B 17/00(2006.01)
(86) International application number:
PCT/US2002/028635
(87) International publication number:
WO 2003/022133 (20.03.2003 Gazette 2003/12)

(54)

BIOPSY MARKER DELIVERY SYSTEM

BIOPSIEMARKER-ABGABESYSTEM

SYSTEME D'ADMINISTRATION DE MARQUEURS DE BIOPSIE

(84) Designated Contracting States:
DE FR GB IT NL

(30) Priority: 10.09.2001 US 954792

(43) Date of publication of application:
09.06.2004 Bulletin 2004/24

(73) Proprietor: Devicor Medical Products, Inc.
Pleasant Prairie, WI 53158 (US)

(72) Inventors:
  • ZARINS, Sascha
    San Jose, CA 95130 (US)
  • KIM, Steven
    San Jose, CA 95125 (US)

(74) Representative: Tunstall, Christopher Stephen et al
Carpmaels & Ransford One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A-01/08578
US-A- 5 902 310
US-A- 5 906 599
US-B1- 6 220 248
 WO-A-96/27328
US-A- 5 906 599
US-A- 6 056 700
US-B1- 6 350 244
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).